PHVS
Pharvaris N.V.
There isn't enough reported data to score PHVS yet.
PHVS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
PHVS's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
PHVS PE Valuation
PHVS has no meaningful PE right now: it lost money over the past year.
PHVS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Moderate |
Analysts expect PHVS's losses to grow, with revenue growing.
PHVS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$3.00 | +$0.43 |
| Q1 2026 | -$3.14 | -$0.02 |
| Q4 2025 | -$3.41 | -$0.65 |
| Q3 2025 | -$3.24 | -$0.52 |
| Q2 2025 | -$3.43 | -$0.92 |
| Q1 2025 | -$3.12 | -$0.45 |
| Q4 2024 | -$2.76 | +$0.07 |
| Q3 2024 | -$2.72 | +$0.72 |
PHVS lost $3.00 per share over the past year, a smaller loss than the year before.
PHVS Quarterly Revenue
PHVS's revenue is shrinking: $0 last quarter.
PHVS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$42M | -$8.7M |
| Q1 2026 | -$55.1M | -$12.2M |
| Q4 2025 | -$42.2M | -$3.2M |
| Q3 2025 | -$34.1M | +$3.2M |
| Q2 2025 | -$33.3M | -$2.5M |
| Q1 2025 | -$42.9M | -$16M |
| Q4 2024 | -$39M | -$12.5M |
| Q3 2024 | -$37.3M | -$11.1M |
PHVS has burned cash in almost every quarter: −$173M over the past year, against −$153M the year before.
PHVS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.2% | +2.8M shares |
| 1 year | +24% | +13.4M shares |
| 3 years | +97% | +33.5M shares |
| 5 years | +105% | +34.9M shares |
| Available history | +114% | +36.2M shares |
PHVS has 68M diluted shares, up 24% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
PHVS hasn't bought back shares in the past year.
PHVS Net Leverage
PHVS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
PHVS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.9 | Neutral |
| Stochastic | 40.1 | Neutral |
PHVS's weekly RSI is 54 (neutral) and its Stochastic is 40 (neutral).
PHVS PE vs Healthcare Sector
PHVS has no meaningful PE right now: it lost money over the past year.
PHVS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.9 | 6.1% above |
| 20 week MA | $33.9 | 0.1% below |
| 50 week MA | $30.3 | 12% above |
| 100 week MA | $24.9 | 36% above |
| 200 week MA | $21.5 | 58% above |
PHVS's trend is mixed: it's above four of its five weekly moving averages, and 58% above its 200-week average.
PHVS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $29.0 | $15.8 | -46% |
| 2022 | $15.8 | $9.91 | -37% |
| 2023 | $9.91 | $28.1 | +183% |
| 2024 | $28.1 | $19.4 | -31% |
| 2025 | $19.4 | $25.8 | +33% |
| 2026 YTD | $25.8 | $33.8 | +31% |
PHVS's yearly returns have swung widely, from +183% in 2023 to −46% in 2021. It's up 31% so far in 2026.